How Tissue Stiffness Affects Nanoparticle Medicines for Diseases like Cancer

Mechanoregulators of Nanoparticle-Cell Interactions at Tissue Interfaces

['FUNDING_OTHER'] · UNIVERSITY OF NORTH TEXAS · NIH-11141848

This research explores how the stiffness and movement of body tissues change how tiny medicine particles get into cells, aiming to make treatments for conditions like cancer more effective.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF NORTH TEXAS (nih funded)
Locations1 site (DENTON, UNITED STATES)
Trial IDNIH-11141848 on ClinicalTrials.gov

What this research studies

Many diseases, including cancer, cause body tissues to become stiffer or change how they move. This project looks at how these changes in tissue mechanics affect the way tiny medicine particles, called nanoparticles, enter our cells. Current lab models often don't capture these real-world tissue conditions, which can limit how well new nanoparticle medicines work. We are creating advanced tissue models that mimic the stiffness and movement found in the body, especially in lung and blood vessel tissues. By understanding how these mechanical forces guide nanoparticles into cells, we hope to design smarter nanoparticles that can deliver medicines more efficiently.

Who could benefit from this research

Good fit: This foundational research does not directly involve patients but aims to benefit those with diseases where tissue stiffness or movement changes, such as certain cancers, pulmonary fibrosis, or hypertension.

Not a fit: Patients whose conditions are not related to altered tissue mechanics or nanoparticle drug delivery may not directly benefit from this specific line of research.

Why it matters

Potential benefit: If successful, this work could lead to the development of more effective nanoparticle-based treatments for diseases like cancer, pulmonary fibrosis, and hypertension by improving drug delivery to target cells.

How similar studies have performed: While the influence of tissue stiffness on cell behavior is known, how these changes specifically affect nanoparticle delivery, especially under dynamic forces, is less understood, making this a novel area of focus.

Where this research is happening

DENTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Cancers

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.